Fda Losartan Recall

The usual initial dosage of metoprolol tartrate tablets is 100 mg daily in single or divided doses, whether used alone or added to a diuretic. Additional recalls of medications containing losartan and irbesartan followed. Tests of some of those medications revealed amounts of N-methylnitrosobutyric acid (NMBA) that were above the US Food and Drug Administration's daily acceptable levels. com for more details. The recall affects 150- and 300-mg capsules produced by Sandoz. But, these drugs are not included in the recall. (CNN) -- If you take blood pressure medicine, you'll want to double-check your bottle. The US Food and Drug Administration says another heart medicine, losartan, is being voluntarily recalled after tests showed that it was tainted with a potential cancer-causing chemical. READ: 137,000 patients affected by losartan high blood pressure medicine recall: MOH. Major - Recall of Losartan. The FDA expands recall of blood pressure drugs again. Food and Drug. BLM715A with an expiration date of July 2019. Major – Recall of Losartan January 10, 2019 - Major announced a voluntary recall of one lot of losartan tablets due to the detection of trace amounts of an unexpected impurity, identified as N-nitrosodiethylamine (NDEA), found in an active pharmaceutical ingredient (API) manufactured by Hetero Labs. Torrent Pharmaceuticals Ltd. Issues Voluntary Nationwide Recall of One Lot of Losartan Potassium and Hydrochlorothiazide Due to the Detection of Trace Amounts of NDEA (N-Nitrosodiethylamine. drug manufacturer found high levels of N-nitrosodimethylamine (NDMA) in the valsartan active ingredient it had bought from a Chinese supplier. In this case, the manufacturer has voluntarily recalled one lot of enalapril/HCTZ 10 mg/25 mg tablets, and four lots of losartan 25 mg, 50 mg, and 100 mg tablets. has expanded its recall of losartan potassium and losartan potassium/hydrochlorothiazide. Issues Voluntary Nationwide Recall of One Lot of Losartan Potassium and Hydrochlorothiazide Due to the Detection of Trace Amounts of NDEA (N-Nitrosodiethylamine. The FDA says it could be more dangerous to stop taking the medication than the potential risk NMBA could cause. Neither losartan nor its metabolite accumulate in plasma upon repeated once-daily dosing. 5mg Tablet Reason Affected lots manufactured with an API that may contain the impurity N-nitroso-N-methyl-4-aminobutyric acid (referred as “NMBA”) above the acceptable level. A Food and Drug Administration recall of a heart medication due to a cancer-causing chemical now includes two blood pressure medications. FDA issued recall of Losartan Potassium Tablets, USP and Losartan Potassium/Hydrochlorothiazide Tablets, USP by Torrent Pharmaceuticals due to impurity. The FDA first recalled valsartan in July after. Torrent Pharmaceuticals Ltd. A drug recall is the Federal Food and Drug Administration's way of protecting the public by removing harmful drugs from being available in pharmacies, drug stores, and store shelves. has expanded its voluntary recall of two blood pressure medications after trace amounts of a potentially cancer-causing impurity were found during testing. Aurobindo Pharma says it is voluntarily recalling tablets. Drug Recall DATE OF RECALL: March 01, 2019 DRUG NAME: Losartan Potassium RECALLING FIRM: Torrent Pharmaceuticals LTD REASON FOR RECALL: This recall was issued due to the detection an unexpected impurity found in an active pharmaceutical ingredient (API) manufactured by Hetero Labs Limited. Between November 2018 and April 2019, close to 300 lots of drugs containing losartan were recalled because potentially cancer-causing substances were found in the medications. A drug recall is the Federal Food and Drug Administration's way of protecting the public by removing harmful drugs from being available in pharmacies, drug stores, and store shelves. FDA issues nationwide recall of blood pressure medications for. Losartan blocks the action of angiotensin II, resulting in the relaxation of the blood vessels. It's available. Recall: Voluntary recall of Losartan Potassium Tablets Dear provider of pharmaceutical services, At PharmPix we are committed to the health and well-being of patients. WASHINGTON — If you take blood pressure medicine, you'll want to double-check your bottle. The recall includes three additional lots of losartan potassium tablets and two lots of losartan potassium. It is for specific lots of losartan and losartan containing products1. According to the FDA, the recall was issued after trace amounts of an impurity that might be a carcinogen. The recall of Losartan is linked to a possible cancer-causing element known as NMBA. >> Read more trending news. Reason for the Shortage. Food and Drug Administration announced. Torrent Pharmaceuticals Ltd. 5 mg and, if blood pressure remains uncontrolled after about 3 weeks of therapy, increase the dose to two tablets of losartan potassium and hydrochlorothiazide 50 mg/12. -based Mylan Pharmaceuticals expanded its recall of all lots of Valsartan blood pressure products, including combination tablets, with Amlodipine and Hydrochlorothiazide, because of potential. Posted: 7:37 AM, Sep 24, 2019. Drug maker Torrent Pharmaceuticals said it is expanding a recall of Losartan potassium tablets because it detected trace amounts of N-nitrosodiethylamine above permitted FDA levels. A Losartan lawsuit is a mass tort claim against the pharmaceutical companies that make generic medication containing the drug Losartan. The announcement targets an additional five lots of the generic drug Losartan, which is made by Torrent Pharmaceuticals Limited. The FDA has added 80 lots of Amlodipine Valsartan blood pressure medication to the hypertension drug recall list that continues to grow. Voluntary Drug Recall on Losartan Products April 4, 2019 Torrent Pharmaceuticals (Torrent) announced on March 1, 2019, that it’s issuing a nationwide, voluntary recall on 60 lots of Losartan potassium tablets USP and 54 lots of Losartan potassium/hydrochlorothiazide tablets. Keep giving this drug to your child as you have been told by your child’s doctor or other health care provider, even if your child feels well. Here are the lots to look for. This latest recall is related to the valsartan recall that has been expanded multiple times since July. If you take blood pressure medicine, you'll want to double-check your bottle. Today a second recall on a high blood pressure med my doctor has prescribed in a year. It basically removes a drug, both over-the-counter and prescribed, from the market. The voluntary recall began with two lots of Losartan potassium tablets USP on Jan. Individualize the dosage of metoprolol tablets. The US Food and Drug Administration said Thursday that Torrent Pharmaceuticals has added eight additional lots of losartan potassium tablets to its recall list. Now company officials have added an additional. The losartan recall is for lot number JB8912. Important recall information for Losartan Potassium 100mg Tablets We wanted to let you know that certain manufacturers have issued a recall of select lots of Losartan Potassium 100mg Tablets. All recalls are due to the presence of NDEA. Food & Drug Administration (FDA. June 11, 2019 - The FDA announced a consumer-level recall of Teva’s losartan tablets due to the detection of an impurity, N-Nitroso-N-methyl-4-aminobutyric acid (NMBA), that is above the FDA’s interim acceptable exposure limit of 9. What’s Better: Losartan or Valsartan? Dr. If the recall involves an over-the-counter drug, stop taking it at once. Torrent Pharmaceuticals Ltd. The voluntary recall affects Losartan Potassium Tablets USP and Losartan Potassium-Hydrochlorothiazide Tablets. losartan and irbesartan - alone or in combination with other drugs - after. In July 2018, the FDA announced the recall for several types of generic valsartan, indicating that the manufacturing process has resulted in impurities, including a substances known as N-nitrosodimethylamine (NDMA), which is a known to increase the risk of cancer. The recall was first. Losartan is used to treat hypertension, heart failure and nephropathy in type 2 diabetic patients. The measure is designed to avert a shortage of the critical medication – the nation’s ninth-most commonly prescribed drug. Torrent Pharmaceuticals Ltd. You can return the product to the place of purchase and ask for a. Patients who have been using Losartan since 2012 may experience complications due to manufacturing contamination. The recalls are due to impurities from N-Nitroso-N-methyl-4-aminobutyric acid (NMBA), as well as NDMA and NDEA, which are classified as a potential human carcinogen. The losartan recall is for lot number JB8912. To Prevent Losartan Shortages, FDA Allows Higher Impurity Levels Posted 21 March 2019 | By Zachary Brennan To ensure patient access to the blood pressure medicine losartan, the US Food and Drug Administration (FDA) said late Wednesday that it will not object to certain manufacturers temporarily distributing losartan with one impurity above the. Significant levels of losartan and its active metabolite were present in rat fetal plasma during late gestation and in rat milk; Lactation. Losartan potassium is a drug used to treat high blood pressure and heart failure. Torrent said six. The FDA has set up several web pages to help consumers identify whether or not their particular medications are affected. A nationwide blood pressure medication recall has been expanded. Since then there have been four additional recalls this being number five. The recall was first. FDA chief: Drug recalls reflect new scrutiny on makers A Sandoz representative said the drug company detected the impurity in its losartan drug ingredient during routine testing. Here are the lots to look for. Hypertension. Update [11/9/2018] FDA is alerting patients and health care professionals to Sandoz's voluntary recall of one lot - JB8912 - of losartan potassium and hydrochlorothiazide 100mg/25mg tablets, that contain losartan, an angiotensin II receptor blocker (ARB), and hydrochlorothiazide, a diuretic, used in combination for the treatment of. The agency pointed out that Sandoz’s losartan drug products make up less than 1% of the total losartan drug products in the U. FDA Again Expands Recall of Popular Blood Pressure Drugs The latest recall targets five lots of the drug losartan sold by Torrent Pharmaceuticals. https://www. A recall has been expanded for a fifth time for several blood pressure medications. The drug had been recalled in 22. gov) earlier this month that it had issued safety alerts regarding voluntary recalls of various drug products containing the active ingredient valsartan, which is used to. Food and Drug Administration announced a third blood pressure medication recall over concerns the contaminated drug might cause cancer. Recall is expanded to include an additional 36 lots of Losartan potassium Tablets USP and 68 lots of Losartan Potassium/Hydrochlorothiazide Tablets, USP. If the recall involves an over-the-counter drug, stop taking it at once. Here are the lots to look for Losartan Potassium Tablets, USP 50mg, 1000 count. Torrent Pharmaceuticals Ltd. One component of Drug Safety Alerts is product recalls. This latest recall affects two lots of Losartan Potassium USP Tablets at. The FDA announcement on the Torrent voluntary recall also referenced the Feb. The product can be identified by checking the product name, manufacturer details and batch or lot number on. As per the report, Torrent Pharma Inc is recalling 17,088 bottles of Losartan Potassium /Hydrochlorothiazide tablets, USP 50mg/12. This ensures that patients in all settings are able to promptly receive the medication needed. gov, July 17, 2018. If you take blood pressure medicine, you'll want to double-check your bottle. Due to the drug recall and to ensure the continued availability of high blood pressure medication for all patients who need them, you will be given the medication on a one-month basis. WASHINGTON – The Food and Drug Administration has again expanded a recall for medication used to treat high blood pressure over contamination with a chemical linked to cancer. Losartan is a prescription medication that is used to treat high blood pressure and congestive heart failure. FDA widens its recall of tainted blood pressure drugs New romaine recall: Parasites lurking in packaged salads and wraps The real danger may be among consumers who hav not yet heard about the recall. This is the third blood pressure drug to have been recalled due to possible cancer risk. Jun 26, 2019 · Blood pressure drug recall: 32 lots of losartan recalled over small amounts of carcinogen. The recall started on April 25 in the US, and has now. If your drug is on the recall list, the FDA suggests taking it until your doctor. Making sense of the recent blood pressure drug recalls. Losartan potassium is used to treat kidney disease in patients with diabetes and to control high blood pressure. If you take blood pressure medicine, you’ll want to double-check your bottle. Torrent Pharmaceuticals Ltd. FOR IMMEDIATE RELEASE- September 23. March 2 (UPI) --Drug companies expanded a recall of Losartan lots after detecting a third potentially cancer-causing impurity in blood pressure medication. Losartan potassium is a drug used. is voluntarily recalling losartan. The FDA says it is packed in bottles. The FDA announced a valsartan recall in July after lab tests revealed that some drugs could have been tainted with a substance linked to higher risk of cancer. Search List of Recalled Angiotensin II Receptor Blockers (ARBs) including Valsartan, Losartan and Irbesartan. The US Food and Drug Adminsitration (FDA) and Torrent Pharmaceuticals Limited expanded for the fifth time a warning against using a common blood pressure medication. There have been several reminders of blood pressure medication since July 2018 and now 32 parts of the drug losartan, sold by Macleods Pharmaceuticals, have been added to the. FDA Recalls Some Valsartan Drugs Due to Impurity. NMBA is a potential human carcinogen which means it can be the. The FDA is alerting patients and health care professionals to Sandoz's voluntary recall of one lot - JB8912 - of losartan potassium and hydrochlorothiazide 100mg/25mg tablets, that contain losartan, an ARB, and hydrochlorothiazide, a diuretic, used in combination for the treatment of hypertension. The impurity is N-Methylnitrosobutyric acid. Additional recalls of medications containing losartan and irbesartan followed. FDA and European regulators recall Valsartan distributed by several drug makers. A recall has been expanded for a fifth time for several blood pressure medications. An addition eight lots of Torrent Pharmaceuticals' losartan tablets were added to a previous recall in January. The voluntary recall of losartan. gov: “Mylan Expands Its Voluntary Nationwide Recall of Valsartan Tablets, USP, Amlodipine and Valsartan Tablets, USP, and Valsartan and Hydrochlorothiazide Tablets, USP, to all Lots Within. The measure is designed to avert a shortage of the critical medication – the nation’s ninth-most commonly prescribed drug. Looking for current, comprehensive information about drug recalls and safety alerts? Visit the U. A recall has been expanded for a fifth time for several blood pressure medications. In this case, the manufacturer has voluntarily recalled four lots of three strengths of lisinopril tablets: 2. The recall covers 25 mg, 50 mg and 100 mg dosages. In this case, the manufacturer has voluntarily recalled one lot of enalapril/HCTZ 10 mg/25 mg tablets, and four lots of losartan 25 mg, 50 mg, and 100 mg tablets. Voluntary Drug Recall on Losartan Products April 4, 2019 Torrent Pharmaceuticals (Torrent) announced on March 1, 2019, that it’s issuing a nationwide, voluntary recall on 60 lots of Losartan potassium tablets USP and 54 lots of Losartan potassium/hydrochlorothiazide tablets. has expanded its recall of losartan potassium and. Recall of blood pressure drug losartan expanded If you take blood pressure medicine, you'll want to double-check your bottle. My pharmacist was proactive when the warning/recall was issued and already had the information waiting for any person who inquired. The recall is expanding. Macleods Pharmaceuticals Limited has voluntarily recalled the 100 mg/25 Losartan Potassium/Hydrochlorothiazide combination tablets, the U. The post Losartan Potassium Recall Issued Over NDEA Impurities appeared first on AboutLawsuits. Tests of some of those medications revealed amounts of N-methylnitrosobutyric acid (NMBA) that were above the US Food and Drug Administration's daily acceptable levels. The recall information provided here is based on manufacturers' and regulatory agencies' press releases that involve product sold through Walmart stores, Walmart. New Losartan Recall. Following a rash of blood pressure medication recalls over the last two months, Camber Pharmaceuticals has also recalled 87 lots of Losartan Potassium tablets USP for the detection of a cancer. Makers of blood-pressure medication expand their recall. A nationwide blood pressure medication recall has been expanded. Many lots of Losartan, Valsartan and Irbesartan have been recalled for the. The original recall of valsartan was issued because batches were discovered to have been contaminated by a substance believed to cause cancer. Food and Drug Administration (FDA) announced it is expanding the recall of medication used to treat high blood pressure. The FDA advises patients who take these drugs — even the ones that have been. FDA expands recall on blood pressure drug valsartan due to probable carcinogen. The Food and Drug Administration (FDA) says Torrent Pharmaceuticals Limited is expanding its recall of Losartan Potassium. Camber Pharmaceuticals, Inc. If you take blood pressure medicine, you'll want to double-check your bottle. Since the recall, the external supplier linked to the problem has stopped distributing its valsartan ingredient, and the FDA has been working with the affected companies to reduce the chances of. The manufacturer can voluntarily recall their medication or the Food and Drug Administration (FDA) can request or require that a manufacturer recall a particular medication. This latest recall affects two lots of Losartan Potassium USP Tablets at. Sandoz's product was made using an active. Torrent Pharmaceuticals Ltd. "We want to ensure that patients who take montelukast are aware of this recall due to the serious risks associated with taking losartan in its place," said Donald D. Apr 19, 2019 · Torrent Pharmaceuticals Ltd. Losartan recall: Blood pressure drug recall expands - CNN Torrent Pharmaceuticals Ltd. The recall is due to an "impurity" that is classified as a. gov, July 17, 2018. The FDA report goes on to say that Sandoz has not received any reports of adverse events related to the affected lot. CLEVELAND, Ohio (WOIO) - Several blood pressure medications have been recalled after exposure that could pose a cancer risk. 3 Companies Recall Blood. Losartan potassium is a drug used. Major - Recall of Losartan. Innoveix Pharmaceuticals, Inc. Recall of Losartan Potassium Tablets On January 3, 2019 , the manufacturer (Torrent Pharmaceuticals Limited) of losartan potassium tablets recalled certain lots of the product. If you take blood pressure medicine, you'll want to double-check your bottle. FDA Expands Recall Of Blood Pressure Drugs Again. The recall is expanding from 10 lots of Losartan potassium tablets USP to include six lots of Losartan potassium and hydrochlorothiazide tablets, USP due to detection of trace amounts of an unexpected impurity, FDA said. Torrent is only recalling lots of losartan containing products that contain Nitrosodiethylamine (NDEA) above the acceptable daily intake levels released by the FDA. Story highlights. Torrent Pharmaceuticals Limited is expanding its recall for Losartan Potassium Tablets USP and Losartan Potassium/hydrochlorothiazide tablets, USP, to the consumer level due to the detection of trace amounts of an unexpected impurity while testing the below finished product batches manufactured. If your drug is on the recall list, the FDA suggests taking it until your doctor. Sandoz Recalls Losartan Potassium and Ezetimibe Prescription Drug Bottles Due to Failure to Meet Child-Resistant Closure Requirements News provided by U. The FDA announced the latest Torrent Losartan recall on September 19, 2019, and the company issued a formal announcement of the recall on September 23. The recall of popular heart drugs has expanded yet again. Drug recall notice for losartan and losartan-containing drug products January 4, 2019 The Food and Drug Administration (FDA) has issued a voluntarily recall of select losartan containing drugs due to an impurity used in the manufacturing of these medicines. The current action by Torrent expands the recall to 3 additional lots of losartan potassium and losartan potassium/hydrocholorothiazide. A global recall was set off last summer when the FDA and EU learned that the valsartan API made by Huahai contained the. Doctors prescribe losartan for patients with high blood pressure and for Type 2 diabetics who have nephropathy. The recall affects 150- and 300-mg capsules produced by Sandoz. The tablets could have trace amounts of an. Food and Drug Administration (FDA) announced that Heritage Pharmaceuticals Inc. In July 2018, the FDA announced the recall for several types of generic valsartan, indicating that the manufacturing process has resulted in impurities, including a substances known as N-nitrosodimethylamine (NDMA), which is a known to increase the risk of cancer. Food and Drug Administration announced. has expanded its recall of losartan potassium and losartan potassium/hydrochlorothiazide. Important recall information for Losartan Potassium 100mg Tablets We wanted to let you know that certain manufacturers have issued a recall of select lots of Losartan Potassium 100mg Tablets. This is the fifth time the company has expanded its voluntary recall of losartan in 2019. has expanded its recall of losartan potassium and losartan potassium. COMPANY ANNOUNCEMENT. The FDA expects that in six months, the manufacturing issue will be solved and that many companies will be able to manufacture losartan without any impurities. Food and Drug Administration announced Monday that Torrent Pharmaceuticals Limited has expanded its recall of blood pressure medicine after finding trace amounts of N-Methylnitrosobutyric. Research "losartan and Marfan" (even if you don't have Marfan syndrome) to learn more, or click my screenname to read previous posts on. Losartan is used to treat hypertension, heart failure and nephropathy in type 2 diabetic patients. Another Losartan Potassium recall has been issued following two other recalls for blood pressure medication made over the last few weeks. Sandoz Recalls Losartan Potassium and Ezetimibe Prescription Drug Bottles Due to Failure to Meet Child-Resistant Closure Requirements News provided by U. in November over cancer concerns due to an impurity. Updated Jan 29, 2019; Posted Jan 24, 2019. FDA Alerts to Recalls Over Non-Valsartan Product Found to Contain Impurities Posted 01 November 2018 | By Ana Mulero In its latest update on the investigation into impurities detected in a growing body of sartan products, the US Food and Drug Administration (FDA) alerted to recalls initiated by two firms over the presence of the second probable. Since then there have been four additional recalls this being number five. has expanded its recall of losartan potassium and losartan potassium/hydrochlorothiazide. The FDA issued the recall because the product may have a. On your Side Gets Answers is back with more questions from our viewers. 5 mg – 30/Bottle View Details. Today, the agency also issued a press release to provide additional information about its ongoing investigation and another voluntary recall by Hetero/Camber Pharmaceuticals, which was announced on February 28, of 87 lots of losartan potassium tablets (25 mg, 50 mg and 100 mg). (Gray News) – A recall for medication used to treat high blood pressure has expanded for a fourth time, targeting more variants of generic losartan produced by Torrent Pharmaceuticals. Friday the FDA announced a voluntary recall of some drugs containing valsartan due to an "impurity" A week ago the drug was recalled in 22 other countries. The recall was issued because a trace amount of N-Nitroso N-Methyl 4. The maker of Losartan has widened a recall of the generic blood pressure medicine for the fifth time, according to the U. The company is to recall the affected batches of the product from the distributors, wholesalers and retailers. Torrent Pharmaceuticals announced an initial recall on December 20 after finding NDEA in 2 lots of the active ingredient manufactured by Hetero Labs Limited. If you take blood pressure medicine, you’ll want to double-check your bottle. The FDA issued more drug recalls for blood pressure medication losartan, recalled due to carcinogenic (cancer-causing) trace impurities. Voluntary Drug Recall on Losartan Products April 4, 2019 Torrent Pharmaceuticals (Torrent) announced on March 1, 2019, that it’s issuing a nationwide, voluntary recall on 60 lots of Losartan potassium tablets USP and 54 lots of Losartan potassium/hydrochlorothiazide tablets. — FDA Drug Information (@FDA_Drug_Info) September 20, 2019 The drug, losartan, is used by doctors to treat high blood pressure and heart failure. Some lots of Losartan and Valsartan have recently been partially recalled by the FDA. FDA has also updated the list of losartan medicines under recall to include repackagers of Torrent's and Camber's losartan-containing medicines. Making sense of the recent blood pressure drug recalls. If you take blood pressure medicine, you'll want to double-check your bottle. A recall of common blood pressure medication losartan has been expanded for a fifth time after manufacturer Torrent Pharmaceuticals found a possibly carcinogenic impurity in more batches of the. Furthermore, the FDA has put Zhejiang Huahai on notice for poor or totally absent quality control on tested drugs. The US Food and Drug Administration has announced another recall of the blood pressure medication Losartan. One of the affected tablets. Also, as a reminder, the FDA has described N-nitrosodiethylamine (NDEA) as a “substance that occurs naturally in certain foods, drinking water, air pollution, and industrial. Aurobindo expands recall of drug for impurities from US - Torrent is recalling Losartan-containing products that contain NMBA above the acceptable daily intake levels released by the FDA. This recall involves bottles of prescription medications Losartan Potassium and Ezetimibe from Sandoz with certain lot numbers. Tina, from Wichita e-mailed KAKE News, worried about a drug she takes that's been recalled. Patients who have been using Losartan since 2012 may experience complications due to manufacturing contamination. Torrent is only recalling lots of losartan-containing products that contain N-nitrosodiethylamine (NDEA) above the acceptable daily intake levels released by the FDA. The recall was issued because a trace amount of N-Nitroso N-Methyl 4. Doctors prescribe losartan for patients with high blood pressure and for Type 2 diabetics who have nephropathy. Recall: Losartan Potassium 25 mg, 50 mg and 100 mg Tablets by Vivimed Life Sciences May 6, 2019 10:28 AM FDA issued recall of losartan potassium 25 mg, 50 mg and 100 mg tablets by Vivimed Life Sciences due to trace amounts of n-nitroso-n-methyl-4-aminobutyric acid (NMBA) impurity. The FDA is alerting patients and health care professionals to a voluntary recall of 44 lots of losartan potassium tablets by Teva Pharmaceuticals USA and labeled as Golden State Medical Supply due. ” Sartans are a class of drugs used to treat patients with high blood pressure to help prevent heart attacks and stroke. Torrent Pharmaceuticals Limited is expanding its recall for Losartan Potassium Tablets USP and Losartan Potassium/hydrochlorothiazide tablets, USP, to the consumer level due to the detection of. Class III Recall. The recall is due to an impurity that is classified as a. losartan, or irbesartan can search the FDA's list of recalled ARB. People concerned about the ARB drug they're taking should go to the websites the FDA has created to track all of the recalls, Krakoff said. Torrent Pharmaceuticals expanded a voluntary recall of losartan potassium tablets because there was an unacceptable amount of N-Nitroso-N-methyl-4-aminobutyric acid or NMBA. In the ongoing saga of contaminated sartans, Torrent Pharmaceuticals Limited has expanded its voluntary recall of losartan potassium and hydrochlorothiazide combination tablets to include six more. FDA Alerts to Recalls Over Non-Valsartan Product Found to Contain Impurities Posted 01 November 2018 | By Ana Mulero In its latest update on the investigation into impurities detected in a growing body of sartan products, the US Food and Drug Administration (FDA) alerted to recalls initiated by two firms over the presence of the second probable. The recall includes three additional lots of losartan potassium tablets and two lots of losartan potassium/hydrochlorothiazide tablets by Torrent Pharmaceuticals Limited. Blood pressure medicines losartan, valsartan, amlopidine, irbesartan, hydrochlorothiazide, and more hypertension drugs are under FDA recall. NDEA is a naturally occurring substance that has been classified as a probable human carcinogen by the International Agency for Research on Cancer. "Torrent Pharmaceuticals Ltd. Not all versions of the widely used medications are contaminated, but ongoing recalls may cause shortages, an FDA spokesperson said. Sandoz announced a voluntary recall of certain lots of Losartan Potassium and Ezetimibe prescription bottles due to not meeting federal standards for child-resistant packaging as required by the. has expanded its voluntary recall of two blood pressure medications after trace amounts of a potentially cancer-causing impurity were found during testing. Five lots of the generic drug called losartan have been recalled from the U. 5mg from the same markets. WASHINGTON — If you take blood pressure medicine, you'll want to double-check your bottle. The FDA launched a global recall in 2018 after a U. FDA expands recall on blood pressure drug. This expanded recall includes six (6) lots of bulk losartan potassium USP Tablets (two lots of 50 mg strength and four lots of 100 mg strength) due to the detection of an impurity – N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) – that is above the US Food & Drug Administration’s interim acceptable exposure limit of 9. Injectable solution. Makers of blood-pressure medication expand their recall. Individualize the dosage of metoprolol tablets. It’s lot No. The US Food and Drug Administration said Thursday that Torrent Pharmaceuticals has added eight additional lots of losartan potassium. The company is to recall the affected batches of the product from the distributors, wholesalers and retailers. Beginning in mid-2018, FDA found that several angiotensin II receptor blocker (ARB) medicines contained nitrosamine impurities and have been recalled because they do not meet FDA's safety standards. * Drug Recall Class Class 1 Recall: Reasonable probability that using the drug will cause serious adverse health consequences or death. Torrent Pharmaceuticals Limited announced Thursday it is expanding its recall for Losartan Potassium Tablets USP and Losartan Potassium / hydrochlorothiazide tablets, USP, after trace amounts of N. Losartan is also used to decrease the risk of stroke in people who have high blood pressure and a heart condition called left ventricular hypertrophy (enlargement of the walls of the left side of the heart). Food and Drug Administration (FDA) recently discovered that generic blood pressure drugs containing Losartan were contaminated with carcinogenic chemicals that can cause cancer, causing many companies to recall them. Losartan is used to treat hypertension, hypertensive patients with Left Ventricular Hypertrophy and for the treatment of nephropathy in Type 2 diabetic patients. The recall includes three additional lots of losartan potassium tablets and two lots of losartan potassium. Update [11/9/2018] FDA is alerting patients and health care professionals to Sandoz’s voluntary recall of one lot – JB8912 – of losartan potassium and hydrochlorothiazide 100mg/25mg tablets, that contain losartan, an angiotensin II receptor blocker (ARB), and hydrochlorothiazide, a diuretic, used in combination for the treatment of. On July 13, 2018, FDA alerted health care professionals and patients of a voluntary recall of several drug products containing the active ingredient valsartan, used to treat high blood pressure and heart failure. Sandoz, a generic. Food and Drug Administration (FDA) website. The FDA defines a product recall as actions taken by a firm to remove a product from the market. FDA Press Release , “FDA Announces Preliminary GC/MS Headspace Method…”. This is the fifth time the recall is being expanded; the fourth. has issued a nationwide recall for 87 lots of the blood pressure medication Losartan to the consumer level after routine tests found the product to be contaminated with a potential carcinogen (cancer-causing substance). 18 January 2019 to 25 January 2019 – Solco Healthcare recalls seven lots of irbesartan-containing products, Torrent Pharmaceuticals’ expands its losartan recall to include an additional six lots (16 in total), and Macleods Pharmaceuticals recalls one lot of losartan potassium/hydrochlorothiazide. Update [11/9/2018] FDA is alerting patients and health care professionals to Sandoz’s voluntary recall of one lot – JB8912 – of losartan potassium and hydrochlorothiazide 100mg/25mg tablets, that contain losartan, an angiotensin II receptor blocker. The FDA in July announced the recall of five other valsartan products for NDEA contamination as well as possible contamination from a similar impurity, NDMA. Torrent Pharmaceuticals last week recalled eight. Sandoz recalls losartan products that contain impurity. Originally the company recalled 10 lots of the medication. Losartan potassium hydrochlorothiazide (Losartan) was also recalled by Sandoz Inc. FDA Again Expands Recall of Popular Blood Pressure Drugs The latest recall targets five lots of the drug losartan sold by Torrent Pharmaceuticals. Losartan was recalled because of a carcinogenic chemical impurity known as N-nitrosodiethylamine (NDEA), which is a byproduct of the drug manufacturing process. Sandoz Inc. Recall: Voluntary recall of Losartan Potassium Tablets Dear provider of pharmaceutical services, At PharmPix we are committed to the health and well-being of patients. California State Board of Pharmacy. A growing list of these drugs have been recalled because they are linked to an increased. , in Piscataway, N. Losartan Potassium Tablets, USP 50mg, 1000 count. has expanded its recall of losartan potassium and losartan potassium/hydrochlorothiazide. Torrent Pharmaceuticals Ltd. and distributed by Camber Pharmaceuticals. Torrent Pharmaceuticals Ltd. has expanded its recall of losartan potassium and losartan potassium/hydrochlorothiazide tablets. A recall has been expanded for a fifth time for several blood pressure medications. If the recall involves an over-the-counter drug, stop taking it at once. If you take blood pressure medicine, you'll want to double-check your bottle. FDA expands blood pressure drug recall to include medication containing Losartan. Losartan potassium tablets USP, 25 mg are white, round, biconvex film-coated tablets debossed with “11” on one side and plain on other side. Torrent Pharmaceuticals Limited announced Thursday it is expanding its recall for Losartan Potassium Tablets USP and Losartan Potassium / hydrochlorothiazide tablets, USP. 1 According to the FDA, a recall is defined as an action executed by a manufacturer at any time to remove a defective or harmful drug product from the market when the drug is discovered to be in violation of laws and regulations. The recall includes three additional lots of losartan potassium tablets and two lots of losartan potassium. Torrent Pharmaceuticals Limited is expanding its recall for Losartan Potassium Tablets USP and Losartan Potassium/hydrochlorothiazide tablets, USP, to the consumer level due to the detection of trace amounts of an unexpected impurity while testing the below. Here are the lots to look for Losartan Potassium Tablets, USP 50mg, 1000 count. Anyone with questions for Camber can call their hotline at 1-866-495-1995 9 a. has expanded its recall of losartan potassium and losartan potassium/hydrochlorothiazide. Torrent Pharmaceuticals Limited has expanded its recall of Losartan potassium tablets USP. The FDA advises patients who take these drugs -- even the ones that have been. The recall is due to an “impurity” that is classified as.